Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and Children

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 14, 2018

Primary Completion Date

December 1, 2023

Study Completion Date

December 31, 2026

Conditions
Skin Wound
Interventions
BIOLOGICAL

EHSG-KF

Transplantation of autologous dermo-epidermal skin substitute EHSG-KF to the experimental area

BIOLOGICAL

STSG

Transplantation of autologous split-thickness skin graft to the control area

Trial Locations (7)

1081

Dept. of Plastic, Reconstructive and Hand Surgery, VU University Medical Center, Amsterdam

1940

Rode Kruis Ziekenhuis, Beverwijk

8032

University Children's Hospital Zurich, Zurich

8091

University Hospital Zurich, Zurich

Unknown

Chirurgia Plastica e Centro Ustioni Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli, Napoli

Unità di Chirurgia Plastica e Ustioni Ospedale Santobono, Napoli

U.O.C. Grandi Ustionati Azienda Ospedale Università Padova, Padua

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Wyss Zurich

UNKNOWN

collaborator

Julius Clinical

INDUSTRY

collaborator

Sintesi Research Srl

INDUSTRY

collaborator

University Hospital, Zürich

OTHER

collaborator

University of Zurich

OTHER

lead

CUTISS AG

INDUSTRY